Will the 40-gene expression classifier predict responders to EGFR targeted chemotherapy for the invasive bladder cancer patients?
1 Department of Surgery, Harvard Medical School, Boston, MA 02114, USA ; 2 Division of Cancer Biology and Therapeutics, Department of Surgery and Biomedical Sciences, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA ; 3 Department of Medicine, University of California, Los Angeles, CA 90095, USA ; 4 Department of Urology, Chungbuk National University College of Medicine, Cheongju 361-763, Republic of Korea.
Jayoung
J
Kim
1 Department of Surgery, Harvard Medical School, Boston, MA 02114, USA ; 2 Division of Cancer Biology and Therapeutics, Department of Surgery and Biomedical Sciences, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA ; 3 Department of Medicine, University of California, Los Angeles, CA 90095, USA ; 4 Department of Urology, Chungbuk National University College of Medicine, Cheongju 361-763, Republic of Korea.
Wun-Jae
WJ
Kim